Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZR60
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,716
Award facts
- Contract value 100% obligated
- $34,715.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $34,715.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS and has an ultimate completion date of April 7, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the medical supply needs of Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FZR60?
SPE2DB25FZR60 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 17, 2025.
How much is contract SPE2DB25FZR60 worth?
The government has obligated $34,716 on SPE2DB25FZR60.
Is contract SPE2DB25FZR60 an order under another contract?
Yes. SPE2DB25FZR60 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZR60 competed?
The extent of competition for SPE2DB25FZR60 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award